DE2920890A1 - Neue physiologisch aktive derivate des esterastins sowie verfahren zur herstellung derselben - Google Patents

Neue physiologisch aktive derivate des esterastins sowie verfahren zur herstellung derselben

Info

Publication number
DE2920890A1
DE2920890A1 DE2920890A DE2920890A DE2920890A1 DE 2920890 A1 DE2920890 A1 DE 2920890A1 DE 2920890 A DE2920890 A DE 2920890A DE 2920890 A DE2920890 A DE 2920890A DE 2920890 A1 DE2920890 A1 DE 2920890A1
Authority
DE
Germany
Prior art keywords
esterastin
manufacturing
same
physiologically active
active derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2920890A
Other languages
English (en)
Other versions
DE2920890C2 (de
Inventor
Hamao Umezawa
Takaaki Aoyagi
Tomio Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6172678A external-priority patent/JPS54154754A/ja
Priority claimed from JP6172578A external-priority patent/JPS54154753A/ja
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of DE2920890A1 publication Critical patent/DE2920890A1/de
Application granted granted Critical
Publication of DE2920890C2 publication Critical patent/DE2920890C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/56—Streptomyces lavendulae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE2920890A 1978-05-25 1979-05-23 Esterastin-Derivate und Verfahren zu deren Herstellung Expired DE2920890C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6172678A JPS54154754A (en) 1978-05-25 1978-05-25 Beta-lactone derivative of antiesterase active substance delta-hydroxymicolic acid and its preparation
JP6172578A JPS54154753A (en) 1978-05-25 1978-05-25 Tetrahydroesterastin and its preparation

Publications (2)

Publication Number Publication Date
DE2920890A1 true DE2920890A1 (de) 1979-11-29
DE2920890C2 DE2920890C2 (de) 1982-07-15

Family

ID=26402792

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2920890A Expired DE2920890C2 (de) 1978-05-25 1979-05-23 Esterastin-Derivate und Verfahren zu deren Herstellung

Country Status (5)

Country Link
US (1) US4202824A (de)
CA (1) CA1133921A (de)
DE (1) DE2920890C2 (de)
FR (1) FR2426679B1 (de)
GB (1) GB2023604B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931463A (en) * 1984-12-21 1990-06-05 Hoffmann-La Roche Inc. Oxetanones

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56128774A (en) * 1980-03-14 1981-10-08 Microbial Chem Res Found New physiologically active substance ebelactone and its preparation
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
IL97148A (en) * 1990-02-26 1996-11-14 Hoffmann La Roche Oxtanones, the process for their preparation and the pharmaceutical preparations containing them
US5260310A (en) * 1990-02-26 1993-11-09 Hoffmann-La Roche Inc. Oxetanone compounds and pharmaceutical compositions containing them
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
US5474993A (en) * 1994-06-14 1995-12-12 Sterling Winthrop, Inc. Lactam inhibitors of cholesterol esterase
WO2000013667A1 (en) 1998-09-08 2000-03-16 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
WO2001032616A2 (en) * 1999-10-29 2001-05-10 John Jason Gentry Mullins Oxetanone derivatives
WO2005005403A2 (en) * 2003-07-15 2005-01-20 Ranbaxy Laboratories Limited Process for preparation of oxetan-2-ones
US20090171104A1 (en) * 2005-10-05 2009-07-02 Killol Patel Process for the preparation of orlistat
EP2164839A2 (de) * 2007-06-06 2010-03-24 Ranbaxy Laboratories Limited Verfahren zur herstellung von orlistat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931463A (en) * 1984-12-21 1990-06-05 Hoffmann-La Roche Inc. Oxetanones
US5175186A (en) * 1984-12-21 1992-12-29 Hoffmann-La Roche Inc. Oxetanones

Also Published As

Publication number Publication date
FR2426679B1 (de) 1982-05-14
CA1133921A (en) 1982-10-19
DE2920890C2 (de) 1982-07-15
US4202824A (en) 1980-05-13
GB2023604B (en) 1982-07-28
GB2023604A (en) 1980-01-03
FR2426679A1 (de) 1979-12-21

Similar Documents

Publication Publication Date Title
ATA859578A (de) Verfahren zur herstellung von lokalanoesthetisch wirksamen kombinationspraeparaten
ATA910981A (de) Verfahren zur herstellung kosmetischer und therapeutischer zusammensetzungen
IT1121976B (it) Procedimento per la fabbricazione di forme ed anime da fonderia
DE2920890A1 (de) Neue physiologisch aktive derivate des esterastins sowie verfahren zur herstellung derselben
AT369385B (de) Verfahren zur herstellung von 4'-epidaunorubicin und 3',4'-diepidaunorubicin
AT370086B (de) Verfahren zur herstellung des d-camphorats von l-carnitinamid
ATE24495T1 (de) Imidazolylphenylamidine, verfahren zur herstellung, ihre pharmazeutische anwendung und zwischenprodukte fuer ihre herstellung.
ATA245988A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT362064B (de) Verfahren zur herstellung des neuen 4-spectino- mycylamins und seiner physiologisch ver- traeglichen salze
DD137438A5 (de) Verfahren zur herstellung von n'-phenyl-n-methylharnstoffderivaten
ATA294581A (de) Verfahren zur herstellung von karamelpraeparaten in gepulverter form
AT372279B (de) Verfahren zur herstellung galenischer zubereitungen
AT358163B (de) Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT374183B (de) Verfahren zur herstellung von neuen carbostyril- und oxindolderivaten
DE68913394D1 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
PT69889A (de) Neue substituierte 2-phenylamino-imidazoline-(2) deren saureadditionssalze diese enthaltende arzneimittel und verfahren zur herstellung derselben
DD138770A1 (de) Verfahren zur herstellung von 5-styryl-pyrazolen und ihren vinylogen
PT69643A (de) Verfahren zur stereospezifischen herstellung von imidazolyl-oximetherderivaten und imidazolyl-oximderivaten
ATA611879A (de) Verfahren zur herstellung fester arzneiformen
AR222347A1 (es) Procedimiento mejorado para la preparacion de acidos ascorbico y eritorzico
ATE49760T1 (de) 8-haloalkyl-4h-(1)-benzopyran-4-onen und verfahren zur herstellung.
DD136501A1 (de) Verfahren zur herstellung von 2-furanphosphonsaeuredialkyl-estern und di-2-furylphosphinsaeurealkylestern sowie deren derivaten
DD135078A1 (de) Verfahren zur herstellung von lh-rh und seiner analoga
AT364083B (de) Verfahren zur herstellung der 3-aminorifamycine s und sv

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
D2 Grant after examination
8339 Ceased/non-payment of the annual fee